Abzena picks North Carolina as the home for its 6th manufacturing site, plans to add 325 jobs in Sanford
While Boston and San Francisco are the unquestioned leading biotech hubs in the US, drugmakers — particularly contract manufacturers — are looking elsewhere for cheaper real estate and untapped potential. Now, a San Diego-based biologics maker looking to rapidly scale up is setting down roots in North Carolina.
CDMO Abzena will add 325 jobs in Sanford, NC, as part of a $200 million biologics plant that will eventually house around 24,000 square feet of bioreactor capacity, the company said.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters